首页> 外文OA文献 >Preparation and evaluation of diltiazem hydrochloride-gelucire 43/01 floating granules prepared by melt granulation
【2h】

Preparation and evaluation of diltiazem hydrochloride-gelucire 43/01 floating granules prepared by melt granulation

机译:熔融制粒法制备盐酸地尔硫卓-gelucire 43/01浮粒的制备及评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The basic objective of this study was to explore the application of Gelucire 43/01 for the design of multi-unit floating systems of a highly water-soluble drug diltiazem HCl. Diltiazem HCl-Gelucire 43/01 granules were prepared by melt granulation technique. The granules were evaluated for in vitro and in vivo floating ability, surface topography, and in vitro drug release. Aging effect on storage was vvaluated using scanning electron microscopy, hot stage polarizing microscopy (HSPM), differential scanning calorimetry (DSC), and in vitro drug release. Granules were retained in stomach at least for 6 hours. Approximately 65% to 80% drug was released over 6 hours with initial fast release from the surface. Surface topography, HSPM, DSC study of the aged samples showed phase transformation of Gelucire. The phase transformation also caused significant increase in drug release. In conclusion, hydrophobic lipid, Gelucire 43/01, can be considered as an effective carrier for design of a multi-unit floating drug delivery system of highly water-soluble drugs such as diltiazem HCl.
机译:这项研究的基本目的是探索Gelucire 43/01在设计高度水溶性药物地尔硫卓HCl的多单元漂浮系统中的应用。通过熔融制粒技术制备盐酸地尔硫卓-Gelucire 43/01颗粒。评价颗粒的体外和体内漂浮能力,表面形貌和体外药物释放。使用扫描电子显微镜,热阶段偏光显微镜(HSPM),差示扫描量热法(DSC)和体外药物释放来评估老化对储存的影响。将颗粒保留在胃中至少6小时。在6小时内释放了约65%至80%的药物,并开始从表面快速释放。老化样品的表面形貌,HSPM,DSC研究表明Gelucire发生了相变。相变还引起药物释放的显着增加。总之,疏水性脂质Gelucire 43/01可被视为设计高水溶性药物(如地尔硫卓HCl)的多单元漂浮药物递送系统的有效载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号